Acquired Immunodeficiency Syndrome
"Acquired Immunodeficiency Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993.
Descriptor ID |
D000163
|
MeSH Number(s) |
C02.782.815.616.400.040 C02.800.801.400.040 C02.839.040 C20.673.480.040
|
Concept/Terms |
Acquired Immunodeficiency Syndrome- Acquired Immunodeficiency Syndrome
- Immunologic Deficiency Syndrome, Acquired
- Acquired Immune Deficiency Syndrome
- Acquired Immuno-Deficiency Syndrome
- Acquired Immuno Deficiency Syndrome
- Acquired Immuno-Deficiency Syndromes
- Immuno-Deficiency Syndrome, Acquired
- Immuno-Deficiency Syndromes, Acquired
- Syndrome, Acquired Immuno-Deficiency
- Syndromes, Acquired Immuno-Deficiency
- Immunodeficiency Syndrome, Acquired
- Acquired Immunodeficiency Syndromes
- Immunodeficiency Syndromes, Acquired
- Syndrome, Acquired Immunodeficiency
- Syndromes, Acquired Immunodeficiency
- AIDS
|
Below are MeSH descriptors whose meaning is more general than "Acquired Immunodeficiency Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Acquired Immunodeficiency Syndrome".
This graph shows the total number of publications written about "Acquired Immunodeficiency Syndrome" by people in this website by year, and whether "Acquired Immunodeficiency Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1997 | 2 | 0 | 2 |
1998 | 2 | 0 | 2 |
1999 | 2 | 1 | 3 |
2000 | 2 | 1 | 3 |
2001 | 5 | 0 | 5 |
2003 | 1 | 1 | 2 |
2004 | 5 | 1 | 6 |
2005 | 1 | 3 | 4 |
2006 | 2 | 1 | 3 |
2007 | 5 | 1 | 6 |
2008 | 9 | 2 | 11 |
2009 | 3 | 3 | 6 |
2010 | 0 | 5 | 5 |
2011 | 2 | 2 | 4 |
2012 | 10 | 0 | 10 |
2013 | 2 | 3 | 5 |
2014 | 4 | 4 | 8 |
2015 | 1 | 0 | 1 |
2016 | 5 | 1 | 6 |
2017 | 3 | 2 | 5 |
2018 | 2 | 1 | 3 |
2019 | 2 | 0 | 2 |
2020 | 3 | 0 | 3 |
2021 | 3 | 0 | 3 |
2022 | 10 | 0 | 10 |
2023 | 10 | 0 | 10 |
2024 | 2 | 1 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Acquired Immunodeficiency Syndrome" by people in Profiles.
-
Mortality variability and differentials by age and causes of death in rural South Africa, 1994-2018. BMJ Glob Health. 2024 Apr 08; 9(4).
-
Future HIV epidemic trajectories in South Africa and projected long-term consequences of reductions in general population HIV testing: a mathematical modelling study. Lancet Public Health. 2024 Apr; 9(4):e218-e230.
-
Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age. Pediatr Infect Dis J. 2024 Apr 01; 43(4):355-360.
-
Eita! Reaching Communities and Young People to Drive Demand for Oral Pre-Exposure Prophylaxis in South Africa. J Adolesc Health. 2023 12; 73(6S):S50-S57.
-
Agreement between cause of death assignment by computer-coded verbal autopsy methods and physician coding of verbal autopsy interviews in South Africa. Glob Health Action. 2023 12 31; 16(1):2285105.
-
Virtual case management: a differentiated approach to HIV prevention, treatment, and care. AIDS. 2024 02 01; 38(2):145-151.
-
Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2023 10 01; 94(2):165-173.
-
The Tennessee Center for AIDS Research HIV Research Training Program for Minority High School and Undergraduate Students: Development, Implementation, and Early Outcomes. J Acquir Immune Defic Syndr. 2023 10 01; 94(2S):S42-S46.
-
Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial. BMJ Open. 2023 08 28; 13(8):e076843.
-
Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition. EBioMedicine. 2023 Jul; 93:104590.